Shanghai Medicilon Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 786.3 million compared to CNY 432.94 million a year ago. Revenue was CNY 786.3 million compared to CNY 432.94 million a year ago.

Net income was CNY 180.95 million compared to CNY 74.76 million a year ago. Basic earnings per share from continuing operations was CNY 2.0857 compared to CNY 0.8643 a year ago. Diluted earnings per share from continuing operations was CNY 2.0857 compared to CNY 0.8643 a year ago.